Global and United States Carbapenem-Based Antibiotics Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Carbapenem-Based Antibiotics Revenue in Carbapenem-Based Antibiotics Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Carbapenem-Based Antibiotics Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Carbapenem-Based Antibiotics Market Size for the Year 2017-2028
  • 1.2.2 Global Carbapenem-Based Antibiotics Market Size for the Year 2017-2028
• 1.3 Carbapenem-Based Antibiotics Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Carbapenem-Based Antibiotics in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Carbapenem-Based Antibiotics Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Carbapenem-Based Antibiotics Market Dynamics
  • 1.4.1 Carbapenem-Based Antibiotics Industry Trends
  • 1.4.2 Carbapenem-Based Antibiotics Market Drivers
  • 1.4.3 Carbapenem-Based Antibiotics Market Challenges
  • 1.4.4 Carbapenem-Based Antibiotics Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Carbapenem-Based Antibiotics by Type

• 2.1 Carbapenem-Based Antibiotics Market Segment by Type
  • 2.1.1 Meropenem
  • 2.1.2 Doripenemu
  • 2.1.3 Imipenem
  • 2.1.4 Tebipenemu
  • 2.1.5 Others
• 2.2 Global Carbapenem-Based Antibiotics Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Carbapenem-Based Antibiotics Market Size by Type (2017-2028)
• 2.4 United States Carbapenem-Based Antibiotics Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Carbapenem-Based Antibiotics Market Size by Type (2017-2028)

3 Carbapenem-Based Antibiotics by Application

• 3.1 Carbapenem-Based Antibiotics Market Segment by Application
  • 3.1.1 Retail Pharmacies
  • 3.1.2 Online Pharmacies
  • 3.1.3 Hospital Pharmacies
• 3.2 Global Carbapenem-Based Antibiotics Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Carbapenem-Based Antibiotics Market Size by Application (2017-2028)
• 3.4 United States Carbapenem-Based Antibiotics Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Carbapenem-Based Antibiotics Market Size by Application (2017-2028)

4 Global Carbapenem-Based Antibiotics Competitor Landscape by Company

• 4.1 Global Carbapenem-Based Antibiotics Market Size by Company
  • 4.1.1 Top Global Carbapenem-Based Antibiotics Companies Ranked by Revenue (2021)
  • 4.1.2 Global Carbapenem-Based Antibiotics Revenue by Player (2017-2022)
• 4.2 Global Carbapenem-Based Antibiotics Concentration Ratio (CR)
  • 4.2.1 Carbapenem-Based Antibiotics Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Carbapenem-Based Antibiotics in 2021
  • 4.2.3 Global Carbapenem-Based Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Carbapenem-Based Antibiotics Headquarters, Revenue in Carbapenem-Based Antibiotics Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Carbapenem-Based Antibiotics Headquarters and Area Served
  • 4.3.2 Global Carbapenem-Based Antibiotics Companies Revenue in Carbapenem-Based Antibiotics Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Carbapenem-Based Antibiotics Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Carbapenem-Based Antibiotics Market Size by Company
  • 4.5.1 Top Carbapenem-Based Antibiotics Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Carbapenem-Based Antibiotics Revenue by Players (2020, 2021 & 2022)

5 Global Carbapenem-Based Antibiotics Market Size by Region

• 5.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Carbapenem-Based Antibiotics Market Size by Region (2017-2028)
  • 5.2.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2017-2022
  • 5.2.2 Global Carbapenem-Based Antibiotics Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Carbapenem-Based Antibiotics Market Size YoY Growth 2017-2028
  • 6.1.2 North America Carbapenem-Based Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Carbapenem-Based Antibiotics Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Carbapenem-Based Antibiotics Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Carbapenem-Based Antibiotics Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Carbapenem-Based Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Carbapenem-Based Antibiotics Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Carbapenem-Based Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Carbapenem-Based Antibiotics Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Carbapenem-Based Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 ACS Dobfar S.p.A
  • 7.1.1 ACS Dobfar S.p.A Company Details
  • 7.1.2 ACS Dobfar S.p.A Business Overview
  • 7.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Introduction
  • 7.1.4 ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.1.5 ACS Dobfar S.p.A Recent Development
• 7.2 Iterum Therapeutics plc
  • 7.2.1 Iterum Therapeutics plc Company Details
  • 7.2.2 Iterum Therapeutics plc Business Overview
  • 7.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Introduction
  • 7.2.4 Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.2.5 Iterum Therapeutics plc Recent Development
• 7.3 DAEWOONG PHARMACEUTICAL CO.,LTD
  • 7.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
  • 7.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
  • 7.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Introduction
  • 7.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
• 7.4 Aurobindo Pharma Ltd
  • 7.4.1 Aurobindo Pharma Ltd Company Details
  • 7.4.2 Aurobindo Pharma Ltd Business Overview
  • 7.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Introduction
  • 7.4.4 Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.4.5 Aurobindo Pharma Ltd Recent Development
• 7.5 Gland Pharma Limited
  • 7.5.1 Gland Pharma Limited Company Details
  • 7.5.2 Gland Pharma Limited Business Overview
  • 7.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Introduction
  • 7.5.4 Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.5.5 Gland Pharma Limited Recent Development
• 7.6 Merck & Co., Inc.
  • 7.6.1 Merck & Co., Inc. Company Details
  • 7.6.2 Merck & Co., Inc. Business Overview
  • 7.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Introduction
  • 7.6.4 Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.6.5 Merck & Co., Inc. Recent Development
• 7.7 Sumitomo Dainippon Pharma Co., Ltd.
  • 7.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
  • 7.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  • 7.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Introduction
  • 7.7.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
• 7.8 Savior Lifetec
  • 7.8.1 Savior Lifetec Company Details
  • 7.8.2 Savior Lifetec Business Overview
  • 7.8.3 Savior Lifetec Carbapenem-Based Antibiotics Introduction
  • 7.8.4 Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.8.5 Savior Lifetec Recent Development
• 7.9 Pfizer Inc.
  • 7.9.1 Pfizer Inc. Company Details
  • 7.9.2 Pfizer Inc. Business Overview
  • 7.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Introduction
  • 7.9.4 Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.9.5 Pfizer Inc. Recent Development
• 7.10 Spero Therapeutics
  • 7.10.1 Spero Therapeutics Company Details
  • 7.10.2 Spero Therapeutics Business Overview
  • 7.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Introduction
  • 7.10.4 Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2017-2022)
  • 7.10.5 Spero Therapeutics Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details